Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Entamoeba histolytica | transitional endoplasmic reticulum ATPase, putative | 0.0026 | 0.3141 | 0.5 |
Plasmodium falciparum | cell division cycle protein 48 homologue, putative | 0.0026 | 0.3141 | 1 |
Plasmodium vivax | cell division cycle protein 48 homologue, putative | 0.0026 | 0.3141 | 1 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0017 | 0.1711 | 0.1009 |
Toxoplasma gondii | isocitrate dehydrogenase | 0.0017 | 0.1711 | 0.0647 |
Loa Loa (eye worm) | hypothetical protein | 0.0016 | 0.1544 | 0.0827 |
Toxoplasma gondii | isocitrate dehydrogenase | 0.0017 | 0.1711 | 0.0647 |
Echinococcus multilocularis | tar DNA binding protein | 0.0069 | 1 | 1 |
Schistosoma mansoni | NADP-specific isocitrate dehydrogenase | 0.0017 | 0.1711 | 0.1009 |
Schistosoma mansoni | cell division control protein 48 aaa family protein | 0.0027 | 0.3368 | 0.2806 |
Schistosoma mansoni | tar DNA-binding protein | 0.0069 | 1 | 1 |
Brugia malayi | Isocitrate dehydrogenase | 0.0017 | 0.1711 | 0.1009 |
Loa Loa (eye worm) | vesicle-fusing ATPase | 0.0016 | 0.1544 | 0.0827 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0017 | 0.1711 | 0.1009 |
Trichomonas vaginalis | spermatogenesis associated factor, putative | 0.0027 | 0.3368 | 1 |
Onchocerca volvulus | Transitional endoplasmic reticulum ATPase homolog | 0.0027 | 0.3368 | 0.5 |
Toxoplasma gondii | cell division protein CDC48AP | 0.0016 | 0.1597 | 0.0000097958 |
Trypanosoma brucei | Valosin-containing protein | 0.0026 | 0.3141 | 1 |
Mycobacterium ulcerans | ATPase | 0.0016 | 0.1597 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0069 | 1 | 1 |
Loa Loa (eye worm) | TAR-binding protein | 0.0069 | 1 | 1 |
Echinococcus multilocularis | isocitrate dehydrogenase | 0.0017 | 0.1711 | 0.1009 |
Entamoeba histolytica | cdc48-like protein, putative | 0.0026 | 0.3141 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0069 | 1 | 1 |
Echinococcus multilocularis | isocitrate dehydrogenase 2 (NADP+) | 0.0017 | 0.1711 | 0.1009 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0017 | 0.1711 | 0.1009 |
Loa Loa (eye worm) | RNA binding protein | 0.0069 | 1 | 1 |
Giardia lamblia | AAA family ATPase | 0.0016 | 0.1597 | 0.5 |
Loa Loa (eye worm) | isocitrate dehydrogenase | 0.0017 | 0.1711 | 0.1009 |
Schistosoma mansoni | tar DNA-binding protein | 0.0069 | 1 | 1 |
Schistosoma mansoni | cell division control protein 48 aaa family protein | 0.0026 | 0.3141 | 0.2559 |
Trypanosoma cruzi | Valosin-containing protein, putative | 0.0026 | 0.3141 | 1 |
Brugia malayi | valosin containing protein | 0.0016 | 0.1544 | 0.0827 |
Leishmania major | Transitional endoplasmic reticulum ATPase, putative,valosin-containing protein homolog | 0.0026 | 0.3141 | 1 |
Brugia malayi | isocitrate dehydrogenase | 0.0017 | 0.1711 | 0.1009 |
Brugia malayi | vesicle-fusing ATPase | 0.0016 | 0.1544 | 0.0827 |
Brugia malayi | TAR-binding protein | 0.0069 | 1 | 1 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0069 | 1 | 1 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0069 | 1 | 1 |
Echinococcus granulosus | tar DNA binding protein | 0.0069 | 1 | 1 |
Toxoplasma gondii | cell division protein CDC48CY | 0.0027 | 0.3368 | 1 |
Echinococcus granulosus | transitional endoplasmic reticulum atpase | 0.0027 | 0.3368 | 0.1998 |
Plasmodium vivax | isocitrate dehydrogenase [NADP], mitochondrial, putative | 0.0017 | 0.1711 | 0.4474 |
Schistosoma mansoni | tar DNA-binding protein | 0.0069 | 1 | 1 |
Mycobacterium tuberculosis | Probable isocitrate dehydrogenase [NADP] Icd1 (oxalosuccinate decarboxylase) (IDH) (NADP+-specific ICDH) (IDP) | 0.0017 | 0.1711 | 1 |
Echinococcus multilocularis | transitional endoplasmic reticulum atpase | 0.0027 | 0.3368 | 0.2806 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.